That is why the $7.4 billion settlement by Purdue Pharma is so important. Purdue Pharma, owners could pay $7.4 billion in new settlement over toll of OxyContin Connecticut will get more than $60 ...

Bankrupt Purdue Pharma and its owners have agreed to pay $7.4 billion (€7.1 billion) to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

Purdue Pharma and its owners have agreed to pay up to $7.4 billion in a new settlement to lawsuits regarding their role in the opioid epidemic, the attorneys general of over a dozen states announced.